TrialBMJ open2025

Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 2 Diabetes (MOTIVATE-T2D): a decentralised feasibility randomised controlled trial delivered across the UK and Canada.

Katie Hesketh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.